patent/US-2018162922-A1

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018162922-A1

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b85b68ef371ec9c8ce0c97811ea032a
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7051 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0638 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-725
filingDate	2017-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb6872e60e5afdcae3994e786edf4eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d802b901e603a1c664c2dcb2b46ab909 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed0b04fb4fc517b925b8d8c135ad888 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40480fb0a7c504ac95f49e9e39461faf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d40dbb9a9f66cc74bc6ec4fd314ee8d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3725e4461eca996b317c9111bb50840c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a8af62bf839a3c2c954967e8fab2a3c
publicationDate	2018-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	US-2018162922-A1
titleOfInvention	T cell receptors with improved pairing
abstract	The present invention relates to modified T cell receptor (TCR) α or β chains, or heterodimers comprising the same, wherein in the variable domain of said modified α or β chain, an amino acid at position 44 according to the IMGT numbering is substituted by another suitable amino acid in order to improve pairing of desired chains.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022147029-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023044488-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022040631-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020243134-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800832-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019256572-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021183643-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023081461-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020191172-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021173560-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102019108125-B4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021285011-A1
priorityDate	2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014083173-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5366546 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409442

Total number of triples: 44.